Document Type : Original Article
Authors
1 Department of Biology, Faculty of Basic Sciences, Islamic Azad University of North Tehran, Tehran, Iran.
2 Reference health laboratory, Ministry of health and medical education
3 Department of Biology, Faculty of Basic Sciences, East Tehran Branch, Islamic Azad University, Tehran, Iran
Abstract
Even if the symptoms during the acute phase are minimal, COVID-19 not only results in severe respiratory problems but also long-term consequences. Significant long-term consequences are now being identified as neurological and neuropsychiatric problems. The onset of neuropsychiatric symptoms brought on by a lengthy COVID might be challenging to detect and treat in patients with behavioral problems, such as those with autism spectrum disorders (ASD). In this article, we describe three instances of ASD that showed a substantial worsening of neuropsychiatric symptoms after exposure to COVID-19 and subsequent difficulties controlling the post-COVID neuropsychiatric symptoms. The therapy intended to target COVID-19-induced immune reaction was delayed because Case 1 caught SARS-CoV-2 in the early phases of the epidemic. Case 2 had a verified COVID-19 exposure but showed no symptoms during the acute phase, however, she later had severe neuropsychiatric symptoms. Case 3 had a challenging course, in part because of underlying immunological dysregulation and the past use of many immunomodulating drugs. Significant variations in peripheral blood monocytes' generation of inflammatory and counter-regulatory cytokines were seen in cases 1 and 3, for which serial blood samples were taken. The instances discussed here show how COVID-19 has a significant impact on neuropsychiatric symptoms in ASD patients as well as how challenging it is to treat long-term COVID side effects.
Keywords
2.Piri GT, Beiranvand S, Doosti A, Ghadiri AH, Haji MS. A review of the epidemiology and clinical signs of SARS-COV-2.2021:103-120.
3.Piri Gharaghie T, Beiranvand S, Ghadiri A, Hajimohammadi S. A review of bioinformatics studies on the function of structural and non-structural proteins and the level of glycoprotein inhibiting Heme metabolism by SARS-CoV-2 virus. Jundishapur Scientific Medical Journal. 2022 May 22;21(2).
4.Korompoki E, Gavriatopoulou M, Hicklen RS, Ntanasis-Stathopoulos I, Kastritis E, Fotiou D, Stamatelopoulos K, Terpos E, Kotanidou A, Hagberg CA, Dimopoulos MA. Epidemiology and organ specific sequelae of post-acute COVID19: a narrative review. Journal of Infection. 2021 Jul 1;83(1):1-6.
5.Walsh-Messinger J, Manis H, Vrabec A, Sizemore, BS J, Bishof K, Debidda M, Malaspina D, Greenspan N. The kids are not alright: a preliminary report of post-COVID syndrome in university students. Journal of American College Health. 2021 May 7:1-7.
6.Kim JH, Levine BD, Phelan D, Emery MS, Martinez MW, Chung EH, Thompson PD, Baggish AL. Coronavirus disease 2019 and the athletic heart: emerging perspectives on pathology, risks, and return to play. JAMA cardiology. 2021 Feb 1;6(2):219-27.
7.Garg M, Maralakunte M, Garg S, Dhooria S, Sehgal I, Bhalla AS, Vijayvergiya R, Grover S, Bhatia V, Jagia P, Bhalla A. The conundrum of ‘long-COVID-19: a narrative review. International journal of general medicine. 2021;14:2491.
8.Sharma S, Nehra A. Cognitive functions in the geriatric population. InResearch Anthology on Diagnosing and Treating Neurocognitive Disorders 2021 (pp. 123-146). IGI Global.
9.Badenoch JB, Rengasamy ER, Watson C, Jansen K, Chakraborty S, Sundaram RD, Hafeez D, Burchill E, Saini A, Thomas L, Cross B. Persistent neuropsychiatric symptoms after COVID-19: a systematic review and meta-analysis. Brain communications. 2022;4(1):fcab297.
10.Lim EJ, Lee JS, Lee EJ, Jeong SJ, Park HY, Ahn YC, Son CG. Nationwide epidemiological characteristics of chronic fatigue syndrome in South Korea. Journal of Translational Medicine. 2021 Dec;19(1):1-6.
11.Zarinnezhad A, Shahhoseini MH, Piri Gharaghie T. Evaluating the Relative Frequency of Fungal Infections in the Serum of Patients with Multiple Sclerosis and Healthy Subjects Using PCR. Biological Journal of Microorganism. 2021 Mar 21;10(37):37-50.
12.Piri-Gharaghie T. Polycystic ovary syndrome and genetic factors influencing its development: A review article. Personalized Medicine Journal. 2021 Dec 1;6(23):25-9.
13.Bucciarelli V, Nasi M, Bianco F, Seferovic J, Ivkovic V, Gallina S, Mattioli AV. Depression pandemic and cardiovascular risk in the COVID-19 era and long COVID syndrome: gender makes a difference. Trends in Cardiovascular Medicine. 2021 Oct 5.
14.De Giacomo A, Pedaci C, Palmieri R, Simone M, Costabile A, Craig F. Psychological impact of the SARS-CoV-2 pandemic in children with neurodevelopmental disorders and their families: Evaluation before and during COVID-19 outbreak among an Italian sample. Rivista di psichiatria. 2021 Jul 1;56(4):205-10.
15.Jyonouchi H, Geng L, Rossignol DA, Frye RE. Long COVID Syndrome Presenting as Neuropsychiatric Exacerbations in Autism Spectrum Disorder: Insights for Treatment. Journal of Personalized Medicine. 2022 Nov 2;12(11):1815.
16.Baweja R, Brown SL, Edwards EM, Murray MJ. COVID-19 pandemic and impact on patients with autism spectrum disorder. Journal of Autism and Developmental Disorders. 2022 Jan;52(1):473-82.
17.Jyonouchi H, Geng L. Associations between monocyte and T cell cytokine profiles in autism spectrum disorders: Effects of dysregulated innate immune responses on adaptive responses to recall antigens in a subset of ASD children. International journal of molecular sciences. 2019 Sep 24;20(19):4731.
18.Eom TH, Lee HS, Jang PS, Kim YH. Valproate-induced panhypogammaglobulinemia. Neurological Sciences. 2013 Jun;34(6):1003-4.
19.Griffith JL, Wong M. The mTOR pathway in treatment of epilepsy: a clinical update. Future neurology. 2018 May;13(2):49-58.
20.Tenório MC, Graciliano NG, Moura FA, Oliveira AC, Goulart MO. N-Acetylcysteine (NAC): impacts on human health. Antioxidants. 2021 Jun 16;10(6):967.
21.Mantovani A, Morrone MC, Patrono C, Santoro MG, Schiaffino S, Remuzzi G, Bussolati G. Long Covid: where we stand and challenges ahead. Cell Death & Differentiation. 2022 Oct;29(10):1891-900.
22.Harden RN, Bruehl S, Stanton-Hicks M, Wilson PR. Proposed new diagnostic criteria for complex regional pain syndrome. Pain medicine. 2007 May 1;8(4):326-31.
23.Padda I, Khehra N, Jaferi U, Mosabbeh D, Atwal H, Musaji A, Bhullar S. Organ system effects and reinfection of COVID-19: A Review. Journal of Research in Clinical Medicine. 2021 Feb 17;9(1):6-.
24.Francistiova L, Klepe A, Curley G, Gulya K, Dinnyes A, Filkor K. Cellular and molecular effects of SARS-CoV-2 linking lung infection to the brain. Frontiers in Immunology. 2021 Aug 13;12:730088.
25.Pelle MC, Zaffina I, Lucà S, Forte V, Trapanese V, Melina M, Giofrè F, Arturi F. Endothelial Dysfunction in COVID-19: Potential Mechanisms and Possible Therapeutic Options. Life. 2022 Oct 14;12(10):1605.
26.Mehandru S, Merad M. Pathological sequelae of long-haul COVID. Nature immunology. 2022 Feb;23(2):194-202.
27.Jyonouchi H, Geng L, Rossignol DA, Frye RE. Long COVID Syndrome Presenting as Neuropsychiatric Exacerbations in Autism Spectrum Disorder: Insights for Treatment. Journal of Personalized Medicine. 2022 Nov 2;12(11):1815.
28.Bonaventura A, Vecchié A, Dagna L, Tangianu F, Abbate A, Dentali F. Colchicine for COVID-19: targeting NLRP3 inflammasome to blunt hyperinflammation. Inflammation Research. 2022 Feb 3:1-5.
29.Mansouri N, Marjani M, Tabarsi P, von Garnier C, Mansouri D. Successful treatment of Covid-19 associated cytokine release syndrome with colchicine. a case report and review of literature. Immunological investigations. 2021 Nov 17;50(8):884-90.
30.Piri-Gharaghie T, Doosti A, Mirzaei SA. Identification of Antigenic Properties of Acinetobacter baumannii Proteins as Novel Putative Vaccine Candidates Using Reverse Vaccinology Approach. Applied Biochemistry and Biotechnology. 2022 Jun 7:1-23.
31.Beiranvand S, Piri‐Gharaghie T, Dehganzad B, Khedmati F, Jalali F, AsadAlizadeh M, Momtaz H. Novel NAD‐independent Avibacterium paragallinarum: Isolation, characterization and molecular identification in Iran. Veterinary Medicine and Science. 2022 May;8(3):1157-65.
32.Souod N, Kargar M, Doosti A, Ranjbar R, Sarshar M. Genetic analysis of cagA and vacA genes in Helicobacter pylori isolates and their relationship with gastroduodenal diseases in the west of Iran. Iranian Red Crescent Medical Journal. 2013 May;15(5):371.
33.Piri-Gharaghie T, Jegargoshe-Shirin N, Saremi-Nouri S, Khademhosseini SH, Hoseinnezhad-Lazarjani E, Mousavi A, Kabiri H, Rajaei N, Riahi A, Farhadi-Biregani A, Fatehi-Ghahfarokhi S. Effects of Imipenem-containing Niosome nanoparticles against high prevalence methicillin-resistant Staphylococcus Epidermidis biofilm formed. Scientific reports. 2022 Mar 24;12(1):1-3.
34.Azadbakht N, Doosti A, Jami MS. CRISPR/Cas9-mediated LINC00511 knockout strategies, increased apoptosis of breast cancer cells via suppressing antiapoptotic genes. Biological procedures online. 2022 Dec;24(1):1-5.
35.Ghajari G, Nabiuni M, Amini E. The association between testicular toxicity induced by Li2Co3 and protective effect of Ganoderma lucidum: Alteration of Bax & c-Kit genes expression. Tissue and Cell. 2021 Oct 1;72:101552.
)